NMR vs IX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 04, 2026
NMR
IX
Investment Advisor Scores
IX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | NMR | IX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 15.3846 | 14.245 | IX |
| PEG Ratio | 0.8146 | 2.7166 | NMR |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 31.2% | 17.4% | NMR |
| Earnings Growth | 42.0% | 170.6% | IX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 67.9/100 | 44.1/100 | NMR |
| Profit Margin | 17.3% | 17.9% | IX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
NMR
NeutralMixed signals - no dominant trend phase, RSI 43
IX
MarkdownPrice below a falling SMA50 (slope -0.5%), weak momentum, RSI 39
Fundamentals Snapshot
| Metric | NMR | IX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 13.1 | 13.7 |
| Trailing P/E | 11.6 | 10.4 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.3% | 0.2% |
| Gross Margin | 0.8% | 0.4% |
| Operating Margin | 0.3% | 0.2% |
| EPS | 0.84 | 3.58 |
| Dividend Yield | 0.03% | 0.03% |